AGEN vs EIKN: stock comparison and AI forecast
Agenus Inc (AGEN) and Eikon Therapeutics, Inc. (EIKN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGEN Agenus Inc
- Market Cap
- $322M
- P/E Ratio
- 65.0x
- Size
- small-cap
- AI Forecast
EIKN Eikon Therapeutics, Inc.
- Price
- $5.90 -40.7% · 6M
- Market Cap
- $320M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AGEN and EIKN have similar market capitalizations ($322M and $320M).
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGEN | EIKN |
|---|---|---|
| Market Cap | $322M | $320M |
| P/E Ratio | 65.00x | – |
| P/B Ratio | – | 0.69x |
| EPS | $0.11 | – |
| Book Value/Share | – | $8.61 |
| Revenue/Share | $2.98 | – |
| FCF/Share | $-2.31 | – |
Profitability & Margins
| Metric | AGEN | EIKN |
|---|---|---|
| ROIC | 124.6% | – |
| Gross Margin | 99.7% | – |
| Operating Margin | 38.9% | – |
| EBT Margin | 51.7% | – |
Financial Health
| Metric | AGEN | EIKN |
|---|---|---|
| Current Ratio | 0.73x | 9.89x |
| D/E Ratio | – | 0.67x |
| Financial Leverage | – | 1.67x |
| Interest Coverage | 21.2x | -18.5x |
| Working Capital | -$55M | $492M |
Cash Flow
| Metric | AGEN | EIKN |
|---|---|---|
| Operating Cash Flow | -$104M | – |
| Free Cash Flow | -$104M | – |
| Capital Spending | $0.00M | – |
| FCF/Sales | -77.5% | – |
| CapEx/Sales | 0.0% | – |
Operational Efficiency
| Metric | AGEN | EIKN |
|---|---|---|
| Asset Turnover | 0.55x | – |
| Receivables Turnover | 7.8x | – |
| Fixed Assets Turnover | 9.6x | – |
| Days Sales Outstanding | 47 days | – |
| Payables Period | 44854 days | – |
Income Statement
| Metric | AGEN | EIKN |
|---|---|---|
| Total Revenue | $134M | – |
| Operating Income | $52M | – |
| R&D Expense | $46M | – |
| Cost of Goods Sold | $380K | – |
Dividend & Shareholder Information
| Metric | AGEN | EIKN |
|---|---|---|
| Shares Outstanding | 45M | 54M |
AGEN vs EIKN: stock comparison and AI forecast
Which is bigger, AGEN or EIKN?
AGEN and EIKN have similar market capitalizations ($322M and $320M).
Which one does Intratio's AI model rank higher, AGEN or EIKN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.